Atreca Inc (NASDAQ:BCEL)
| 0.2675 Delayed Data As of Sep 29 |  -0.0081 / -2.94%Today’s Change | 0.25 Today|||52-Week Range 2.05 | -66.59% Year-to-Date |
Latest BCEL News | Press Releases
No recent news for Atreca Inc.
Today’s Trading
| Previous close | 0.28 |
| Today’s open | 0.29 |
| Day’s range | 0.26 - 0.29 |
| Volume | 598 |
| Average volume (3 months) | 174,267 |
| Market cap | $13.0M |
Data as of 3:45pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +14.71% |
| Earnings growth (this year) | +23.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -9.52% |
| P/E ratio | NM |
| Price/Sales | 40.13 |
| Price/Book | 0.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NMGXNano Magic Inc | 0.00 | 0.00% |
| BCLIBrainstorm Cell Ther... | -0.00 | -2.34% |
| AEZSAeterna Zentaris Inc | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 09/29/2023
Financials
| Next reporting date | November 15, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $770.0K |
| Annual profit (last year) | -$97.2M |
| Net profit margin | -12,617.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
